AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells

Cancer Research

Volumn 61, Issue 2, 2001, Pages 589-593

  Tanno, Satosh ^a   Testa, Joseph R ^b   Kohgo, Yutaka ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; SOMATOMEDIN C RECEPTOR;

ARTICLE; CANCER INVASION; CARCINOGENESIS; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; ONCOGENE SRC; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

BLOTTING, WESTERN; DNA, RECOMBINANT; DOWN-REGULATION; ENZYME ACTIVATION; HUMANS; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; PHOSPHORIC MONOESTER HYDROLASES; PLASMIDS; PRECIPITIN TESTS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RECEPTOR, IGF TYPE 1; SRC-FAMILY KINASES; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 0035863411     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(08)80193-X     Document Type: Article

References (43)

1. Treatment of advanced and metastatic pancreatic cancer
2. Insulin-like growth factors and cancer
3. Overexpression of the human insulin like growth factor 1 receptor promotes ligand-dependent neoplastic transformation
4. Insulin-like growth factor 1 (1GF-1) and the 1GF-I receptor prevent etoposide-induced apoptosis
5. Activation of the insulin-like growth factor-1 receptor inhibits tumor necrosis factor-induced cell death
6. The insulin-like growth factor 1 receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal
7. Insulin-like growth factor 1 overexpression in human pancreatic cancer: Evidence for autocrine and paracrine roles
8. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase
9. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction
10. Activation of RAC-protein kinase by heat shock and hyperosmolarity stress through a pathway independent of phosphatidylinositol 3-kinase
11. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3, 4-bisphosphate
12. A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain
13. Mechanism of activation of protein kinase B by insulin and IGF-1
14. Akt phosphorylation of BAD couples survival signals to the cell- intrinsic death machinery
15. Regulation of cell death protease caspase-9 by phosphorylation
16. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway
17. Overexpression and activation of the tyrosine kinase Src in human pancreatic carcinoma
18. Src stimulates insulin-like growth factor I (IGF-I)-dependent cell proliferation by increasing IGF-I receptor number in human pancreatic carcinoma cells
19. Akt is a direct target of the phosphatidylinositol 3-kinase. Activation by growth factors, v-src and v-Ha-ras, in Sf9 and mammalian cells
20. Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA
21. Isolation of DNA sequences amplified at chromosome 19q13.l-q13.2 including the AKT2 locus in human pancreatic cancer
22. Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas
23. Enhanced invasion and liver colonization by lung carcinoma cells overexpressing the type 1 insulin-like growth factor receptor
24. r 72, 000 type IV collagenase by the type I insulin-like growth factor receptor
25. The regulation of IGF-1 receptor gene expression
26. Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene
27. Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer
28. Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F
29. CREB is a regulatory target for the protein kinase Akt/PKB
30. Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor
31. The mRNA 5′ cap-binding protein eIF4E and control of cell growth
32. Paracrine growth stimulation by hepatocyte-derived insulin-like growth factor-1: A regulatory mechanism for carcinoma cells metastatic to the liver
33. The type I insulin-like growth factor receptor is a motility receptor in human melanoma cells
34. Receptor tyrosine kinase signaling required for integrin αvβ5- directed cell motility but not adhesion on vitronectin
35. Insulin-like growth factors as regulators of cell motility: Signaling mechanisms
36. Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma
37. Basement membrane complexes with biological activity
38. The insulin-like growth factor-I elevates urokinase-type plasminogen activator-1 in human breast cancer cells: A new avenue for breast cancer therapy
39. Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma
40. Expression of plasminogen activators and their inhibitors in human pancreatic carcinoma: Immunohistochemical study
41. Role of MT-MMPs and MMP-2 in pancreatic cancer progression
42. Detection of matrix metalloproteinase activity in human pancreatic cancer
43. Inhibition by platelet-activating factor of Src- and hepatocyte growth factor-dependent invasiveness of intestinal and kidney epithelial cells. Phosphatidylinositol 3′-kinase is a critical mediator of tumor invasion